ANTONIO MARÍA
CABALLERO MATEOS
Investigador en el periodo 2022-2022
Stanisław Sław S.
Gõźdź
Publicaciones en las que colabora con Stanisław Sław S. Gõźdź (38)
2017
-
Data quality in rare cancers registraton: The report of the RARECARE data quality study
Tumori, Vol. 103, Núm. 1, pp. 22-32
-
Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)
Gynecologic Oncology
-
Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)
Gynecologic Oncology
-
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
European Journal of Cancer, Vol. 84, pp. 335-353
-
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413
-
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404
-
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217
2015
-
Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129
-
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
The Lancet, Vol. 385, Núm. 9972, pp. 977-1010
-
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143
-
Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2206-2216
-
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2104-2119
-
Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2217-2230
2014
-
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study
The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34
-
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678
2013
-
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
European Journal of Cancer, Vol. 49, Núm. 3, pp. 684-695
-
Rare neuroendocrine tumours: Results of the surveillance of rare cancers in Europe project
European Journal of Cancer, Vol. 49, Núm. 11, pp. 2565-2578
2012
-
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
European Journal of Cancer, Vol. 48, Núm. 2, pp. 159-169
-
Carcinoma of endocrine organs: Results of the RARECARE project
European Journal of Cancer, Vol. 48, Núm. 13, pp. 1923-1931
-
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe
European Journal of Cancer, Vol. 48, Núm. 8, pp. 1167-1175